Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
13.17
-0.02 (-0.15%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Cross Country Healthcare Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -98.63 | -94.85 | -14.56 | 72.63 | 185.98 | 132 |
Depreciation & Amortization | 15.69 | 16.79 | 18.2 | 18.35 | 12.58 | 9.85 |
Stock-Based Compensation | 7 | 7.14 | 6.03 | 6.58 | 7.39 | 6.89 |
Other Adjustments | 89.88 | 88.7 | 22.82 | 23.46 | 31.81 | 2.89 |
Change in Receivables | 44.1 | 56.73 | 128.33 | 251.43 | -153.23 | -318.42 |
Changes in Accounts Payable | -11.76 | -34.57 | -29.75 | -126.61 | 82.94 | 83.29 |
Changes in Income Taxes Payable | 3.18 | 7.18 | -2.28 | 6.96 | -20.91 | 7.49 |
Changes in Other Operating Activities | -2.12 | 1.13 | -8.67 | -4.29 | -12.52 | -9.61 |
Operating Cash Flow | 47.34 | 48.25 | 120.12 | 248.5 | 134.05 | -85.62 |
Operating Cash Flow Growth | -60.48% | -59.83% | -51.66% | 85.38% | - | - |
Capital Expenditures | -7.73 | -8.16 | -8.71 | -13.97 | -8.79 | -7.17 |
Payments for Business Acquisitions | - | - | - | - | -35.18 | -27.97 |
Other Investing Activities | - | - | - | 0.2 | 0.09 | 1.09 |
Investing Cash Flow | -7.73 | -8.16 | -8.71 | -13.78 | -43.87 | -34.05 |
Short-Term Debt Issued | 1.45 | 1.45 | 18.02 | 720.99 | 1,700 | 443.54 |
Short-Term Debt Repaid | -1.45 | -1.45 | -18.02 | -797.79 | -1,632 | -487.75 |
Net Short-Term Debt Issued (Repaid) | - | 0 | 0 | -76.8 | 67.6 | -44.21 |
Long-Term Debt Issued | - | - | - | - | - | 175 |
Long-Term Debt Repaid | - | - | - | -73.88 | -102.86 | -3.11 |
Net Long-Term Debt Issued (Repaid) | - | - | - | -73.88 | -102.86 | 171.89 |
Repurchase of Common Stock | -14.74 | -8.6 | -40.27 | -62.56 | -40.55 | -2.23 |
Net Common Stock Issued (Repurchased) | -14.74 | -8.6 | -40.27 | -62.56 | -40.55 | -2.23 |
Other Financing Activities | - | -4.41 | -6.58 | -8.01 | -11.78 | -6.35 |
Financing Cash Flow | -14.74 | -13.01 | -46.85 | -221.24 | -87.6 | 119.09 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.02 | 0.02 | -0.01 | 0.01 | -0.01 | 0.01 |
Net Cash Flow | 24.89 | 27.11 | 64.54 | 13.49 | 2.57 | -0.56 |
Free Cash Flow | 39.6 | 40.09 | 111.4 | 234.52 | 125.26 | -92.79 |
Free Cash Flow Growth | -1.21% | -64.01% | -52.50% | 87.22% | - | - |
FCF Margin | 3.95% | 3.80% | 8.29% | 11.61% | 4.47% | -5.53% |
Free Cash Flow Per Share | 1.23 | 1.24 | 3.34 | 6.61 | 3.34 | -2.48 |
Levered Free Cash Flow | -101.37 | -112.48 | -45.77 | -197.62 | 204.02 | 343.52 |
Unlevered Free Cash Flow | -102.8 | -113.51 | -46.19 | -40.01 | 251.62 | 221.89 |